Champions Oncology
CSBR
10 hedge funds and large institutions have $26.2M invested in Champions Oncology in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BPI
Battery Partners IX
Boston,
Massachusetts
|
+$12.8M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$10.2M |
| 3 |
PCM
PAR Capital Management
Boston,
Massachusetts
|
+$5.44M |
| 4 |
PA
Perceptive Advisors
New York
|
+$2.43M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.11M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BPI
1
Battery Partners IX
Boston,
Massachusetts
| $10.5M | +$12.8M | +1,953,549 | New |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $8.36M | +$10.2M | +1,562,500 | New |
|
|
PCM
3
PAR Capital Management
Boston,
Massachusetts
| $4.46M | +$5.44M | +833,333 | New |
|
|
PA
4
Perceptive Advisors
New York
| $1.99M | +$2.43M | +372,597 | New |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| $893K | +$1.11M | +169,397 | New |
|
6
Morgan Stanley
New York
| $14K | +$17.6K | +2,690 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $11K | +$13.6K | +2,089 | New |
|
|
AC
8
Alexandria Capital
Arlington,
Virginia
| $6K | +$7.75K | +1,188 | New |
|
9
UBS Group
Zurich,
Switzerland
| $3K | +$3.15K | +483 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | +$307 | +47 | New |
|
CSBR Hedge Fund Activity: Q3 2015 in Review
10 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2015, worth a combined $26.2M.
Buyers outnumbered sellers: 10 funds opened new CSBR positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Battery Partners IX, opening a new position worth an estimated $12.8M.
- 10 institutional investors held Champions Oncology (CSBR) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $26.2M of Champions Oncology stock for Q3 2015.
- 10 funds opened new Champions Oncology positions in Q3 2015 and 0 closed out, a net change of +10 holders.
- The largest Champions Oncology buyer in Q3 2015 was Battery Partners IX, an estimated $12.8M added.
Based on aggregated 13F filings for Q3 2015.